Biography

Dr. Krystal is a leading expert in the areas of alcoholism, schizophrenia, and post-traumatic stress disorder. His work links psychopharmacology, neuroimaging, molecular genetics, and computational neuroscience to study the neurobiology and to develop novel treatments for these disorders. He is best known for leading the discovery of the rapid antidepressant effects of ketamine in depressed patients.

He is a member of the U.S. National Academy of Medicine. He also serves in a variety of advisory and review capacities for NIAAA, NIMH, Wellcome Trust, Brain and Behavior Research Foundation, and the Karolinska Institutet.

He previously served on the National Alcohol Abuse and Alcoholism Advisory Council (NIAAA), the Department of Defense Psychological Health Advisory Committee, the NIMH Board of Scientific Counselors (chair, 2005-2007), and American College of Neuropsychopharmacology (president, 2012).

Currently, he is president of the International College of Neuropsychopharmacology, a member of the NIMH National Mental Health Advisory Council, and he edits the journal, Biological Psychiatry (impact factor: 11.212).

Neuroimaging studies of brain structure and function associated with psychosis

Rapid Acting Antidepressant Treatment
Taipei, Taiwan (2012 - 2014)

Consulting to a study conducted evaluating the antidepressant effects of ketamine, led by Dr. Tung-Ping (Tom) Su.

Studies of the impact of sexual trauma
Bergen, Norway (2011 - 2016)

I am collaborating with Iris Steine, a Ph.D. candidate at the University of Bergen, as well has her mentors and colleagues, on studies on the clinical features and neurobiology of sexual trauma and its complications, including PTSD

Ketamine Psychosis
Guangzhou, China (2010 - 2014)

Studying the phenomenology and genetics of ketamine psychosis in relation to schizophrenia

The Department of Psychiatry at Cherite Hospital in Berlin has long been a home to ethical and compassionate treatment of patients. However, in the period leading up to World War II, its psychiatry leadership involved the hospital in the emerging eugenics movement. This work, contributed to the...

Related Links

Modal Title

How will my information be used?

When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.

If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.

In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.